10 Stocks to Buy Today: Last Week's Catalysts That Are Still Very Much in Play

A 10 stocks to buy today list is only useful if the story behind each name is still unfolding rather than already closed, which is why every entry on this 10 stocks to buy today list carries a catalyst that remains actively in play this week: a brokerage target still standing, a QIP still being priced, or an order win still working through execution.

Every pick on this 10 stocks to buy today list also comes with its stated risk, a discipline this 10 stocks to buy today list holds to consistently, because an unresolved catalyst can just as easily disappoint as deliver. Position sizing and your own research still matter more than any single day's shortlist, including this one.

Click Here – Get Free Investment Predictions

1-2 on This 10 Stocks to Buy Today List: Brokerage Conviction Still Standing

The first two names on this 10 stocks to buy today list rest on brokerage conviction that has not wavered. HAL remains the highest-conviction name on the list: Citi's target of Rs 6,175, Goldman Sachs' Rs 5,870 and CLSA's Rs 5,481 were all reaffirmed on easing GE F404 engine supply constraints and the start of Tejas Mk1A deliveries, and none of these targets have been walked back since. The risk: the entire thesis still depends on HAL actually converting its roughly Rs 2.3 trillion order backlog into delivered aircraft on schedule.

Also read – NSE Shares Land in Demat Accounts Today: The Stocks to Watch Today Before Thursday's Listing

Premier Energies stays on the list on the strength of becoming India's largest solar cell manufacturer, with 10.6 GW of total capacity after commissioning a 7 GW facility in Andhra Pradesh. The risk: the facility is still in trial-run mode, and the gap between nameplate capacity and actual ramped-up output remains the key unresolved variable for near-term earnings.

3-4: The Welspun Group's Order Momentum

The next two names on this 10 stocks to buy today list belong to the same corporate group. Welspun Corp touched a fresh 52-week high after its Saudi associate EPIC signed a roughly Rs 2,000 crore steel pipe contract with Saudi Aramco, with the earnings impact still to come between Q4 FY27 and Q1 FY28. The risk: the exposure flows through an associate stake, diluting Welspun Corp's actual share of the order's economics relative to the headline figure.

Welspun Enterprises also hit a 52-week high on its subsidiary's Rs 351 crore World Bank-funded sewer rehabilitation win from Ahmedabad Municipal Corporation. The risk: whether this specific niche produces repeat wins is still an open question, and municipal infrastructure work carries payment-timeline risk even with World Bank funding attached.

Stock	Catalyst Still in Play	Key Risk
HAL	Citi/Goldman/CLSA targets, up to 27% upside	Must convert backlog to deliveries
Premier Energies	India largest solar cell capacity, 10.6 GW	Facility still in trial-run mode
Welspun Corp	Rs 2,000 cr Aramco order via associate	Diluted associate-level exposure
Welspun Enterprises	Rs 351 cr World Bank sewer order	Municipal payment-timeline risk
GR Infraprojects	Rs 4,262 cr project appointed date confirmed	Execution-dependent revenue timing
Bharat Forge	Rs 2,000 cr QIP still pricing	Near-term dilution
Knowledge Marine	Third repeat contract from Mumbai Port	Client concentration risk
Rail Vikas Nigam	New East Coast Railway order	Modest order vs overall book
Biocon	First Pertuzumab biosimilar, positive CHMP opinion	EC approval and launch still pending
Elevate Campuses (IPO)	Opens today, anchor book Rs 945 cr	High leverage, related-party use of proceeds

Screen Today's Top Gainers and Catalyst Stocks on Univest

5-7: Confirmed Order Wins Still Working Through Execution

The next three names on this 10 stocks to buy today list are order-driven. GR Infraprojects jumped after NHAI confirmed the appointed date on its Rs 4,262.78 crore Agra-Gwalior project, the milestone that formally starts the execution clock. Bharat Forge is still working through final pricing on its Rs 2,000 crore QIP against a Rs 1,947.70 floor, a live number until the placement actually closes. Knowledge Marine secured its third Green Tug contract from the same Mumbai Port client, a repeat-business pattern worth watching for continuation.

Also read – Welspun Corp Share Price Gains as Saudi Associate Company Bags Rs 2,000 Crore Aramco Order

The seventh name on this 10 stocks to buy today list, Rail Vikas Nigam, added a Rs 404.88 crore East Coast Railway win, a routine but steady contributor to a much larger order book. The risk across all four: none of these are one-time catalysts fully priced in yet, execution over the coming weeks is what determines whether they translate into earnings.

Download the Univest iOS App or Univest Android App to build a watchlist of brokerage and order-backed stocks to buy today.

8: A Regulatory First Still Awaiting Formal Approval

The eighth entry on this 10 stocks to buy today list is a regulatory story. Biocon's Pertuzumab biosimilar became the first of its kind to secure a positive CHMP opinion from the EMA, a genuine first-mover win in a clinically significant oncology category. The risk: formal European Commission approval and a subsequent commercial launch still need to follow before this translates into actual sales, meaning the story is not yet fully played out.

9-10 on This 10 Stocks to Buy Today List: A New IPO Still Taking Shape

The final entries on this 10 stocks to buy today list are not a listed stock at all, but an IPO worth tracking closely. Elevate Campuses opens for subscription today at a price band of Rs 343-362, with anchor investors already committing roughly Rs 945 crore ahead of the public window. The risk: the company carries meaningfully high leverage, with FY26 net debt-to-EBITDA near 5 times, and a meaningful share of proceeds fund a related-party acquisition of K-12 assets from the promoter group's own fellow subsidiaries, details worth reading closely before applying.

Conclusion

This 10 stocks to buy today shortlist deliberately favours names whose catalysts remain unresolved rather than already fully priced in, brokerage targets still standing, a QIP still pricing, orders still executing, and a new IPO still taking shape, with the specific risk stated for every one. None of this guarantees further gains, and every name here still needs your own research on valuation and position sizing. Consult a SEBI-registered investment adviser before making investment decisions.

FAQs

What makes this 10 stocks to buy today list different from a generic tip sheet?

Ans. Every stock on this 10 stocks to buy today list is included specifically because its catalyst remains unresolved or still developing this week, rather than already fully priced in, and each entry states its own risk alongside the rationale.

Which stock on this list has the clearest brokerage backing?

Ans. HAL has the clearest brokerage backing, with Citi, Goldman Sachs and CLSA all maintaining Buy or Accumulate ratings and specific target prices implying up to 27 percent upside.

Which two companies on this list belong to the same corporate group?

Ans. Welspun Corp and Welspun Enterprises both belong to the Welspun Group and both touched fresh 52-week highs on separate confirmed order wins.

Why is Elevate Campuses on this list as an IPO rather than a listed stock?

Ans. The IPO opens for subscription today with anchor investors already committing roughly Rs 945 crore, though investors should note the company's high leverage and related-party use of proceeds before applying.

Why is Biocon included despite regulatory approval still being pending?

Ans. Biocon secured a genuine first-mover regulatory win, a positive CHMP opinion, even though the formal European Commission approval and commercial launch are still to follow.

Does this 10 stocks to buy today list guarantee further gains?

Ans. No. This 10 stocks to buy today list is not a guarantee; every pick carries a stated risk, and an unresolved catalyst can disappoint just as easily as it can deliver; investors should do their own research and consult a SEBI-registered investment adviser.